Mode
Text Size
Log in / Sign up

Sequential reminders improved MenACWY coverage in unvaccinated youth and adults in Spain.

Sequential reminders improved MenACWY coverage in unvaccinated youth and adults in Spain.
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider sequential postal letter and SMS reminders to improve MenACWY catch-up coverage in unvaccinated populations.

This randomized interventional study assessed the impact of various reminder strategies on MenACWY vaccination coverage in the Region of Murcia, Spain. The population comprised 66,891 unvaccinated individuals born between 2001 and 2007. Interventions included different combinations of postal letters, SMS messages, or both, compared against sequential reminders consisting of a postal letter followed by an SMS six weeks later.

Vaccination coverage increased from 53.52% to 56.40% after the first intervention. Following the second intervention, coverage rose to 59.98% at six weeks and reached 61.07% at twelve weeks. This represented a total increase of 7.55 percentage points (p < 0.001). Coverage was significantly higher among minors under 18 years (22.5%) compared to adults (13.2%) (p < 0.001). Among the tested strategies, sequential reminders produced the highest coverage.

Safety and tolerability data, including adverse events or discontinuations, were not reported. The study did not specify funding sources or conflicts of interest. While the practice relevance supports integrating combined reminder strategies into routine catch-up vaccination programs, the lack of reported safety data and uncertainty regarding long-term outcomes beyond twelve weeks warrant cautious interpretation. The study design confirms causality, but the absence of specific safety metrics limits immediate clinical confidence regarding adverse event profiles.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
INTRODUCTION: Invasive meningococcal disease (IMD) in Spain remains rare, yet rising trends in serogroups W and Y prior to 2019 prompted the national recommendation to replace adolescent meningococcal C vaccination with the quadrivalent meningococcal ACWY (MenACWY) vaccine and to implement a catch-up campaign for individuals born between 2001 and 2007. In the Region of Murcia, the COVID-19 pandemic delayed implementation until September 2021. After an initial mass-vaccination phase and a long period without active outreach, coverage remained suboptimal, prompting a multi-phase reminder strategy. This study assessed the impact of different reminder combinations-postal letters, short message service (SMS), or both-on MenACWY vaccination coverage. METHODS: A randomized interventional study was conducted between September and October 2022 among 66,891 unvaccinated individuals. Participants were allocated into four groups based on birth month, each receiving a different reminder strategy: letter followed by SMS, simultaneous letter and SMS, SMS followed by letter, or delayed combined reminders. Coverage was analysed overall and by age group, sex, and intervention arm. RESULTS: Six weeks after the first intervention, coverage increased from 53.52% to 56.40%. After the second intervention, coverage rose to 59.98% at six weeks and 61.07% at twelve weeks-a total increase of 7.55 percentage points. Significant differences were observed across the four strategies (p < 0.001). The most effective approach was sending a postal letter followed by an SMS six weeks later, which consistently produced the highest coverage. No differences were found by sex. Coverage achieved was significantly higher among minors (<18 years) than adults (22.5% vs. 13.2%, p < 0.001). Beyond 12 weeks after each intervention, additional increases were minimal (<1%). CONCLUSIONS: This study demonstrates that sequential reminders-specifically a postal letter reinforced by an SMS-substantially improve adolescent and young adult vaccination uptake. These findings support the integration of combined reminder strategies into routine catch-up vaccination programs.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.